Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 114 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

NCT01026415

Conditions
Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
  • Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
View Trial Details
Completed

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

NCT01561911

Conditions
B-Cell, Cancer, Hemic and Lymphatic Diseases, +8 more
Locations
  • Cancer Research UK Institute for Cancer Studies, University of Birmingham Edgbaston, Birmingham, United Kingdom
  • Cancer Research UK Medical Oncology Unit, Southampton General Hospital Tremona Road,, Southampton, United Kingdom
View Trial Details
Completed

A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120

NCT00715403

Conditions
Neoplasms
Locations
  • 1199.16.3306A Boehringer Ingelheim Investigational Site Bordeaux, France
  • 1199.16.3311A Boehringer Ingelheim Investigational Site Clichy, France
  • 1199.16.3311B Boehringer Ingelheim Investigational Site Clichy, France
  • 1199.16.3302A Boehringer Ingelheim Investigational Site Paris, France
View Trial Details

Related conditions